Marijuana and Dementia: What Research Says About Cannabis (2026)

Marijuana and Dementia: What Caregivers and Patients Need to Know

When someone you love starts wandering at night or becomes frightened and agitated without warning, finding answers can feel overwhelming.These symptoms can be among the most challenging parts of caring for someone with dementia, affecting both the patient and the people supporting them.

While there is currently no cure for dementia or Alzheimer's disease, researchers are studying whether cannabinoids may influence certain symptoms experienced by some people living with dementia, including agitation, sleep disruption, and appetite changes. Importantly, the research focuses on symptom management-not treating or reversing dementia itself.

Here's what current evidence says about cannabis and dementia, where the research is promising, and where important questions remain.

What Dementia Does Beyond Memory Loss

Most people associate dementia with memory problems. While memory loss is one of its defining features, dementia also causes behavioral and psychological symptoms that can become increasingly difficult to manage as the disease progresses.

These may include:

• Severe agitation
• Anxiety
• Restlessness
• Sleep disruption
• Appetite loss
• Irritability
• Aggression
• Wandering

For many families, these symptoms become more difficult to manage than memory impairment itself. They can increase caregiver stress, reduce quality of life, and sometimes lead to hospitalization or long-term care placement.

Current medical treatment focuses on managing these symptoms while helping patients remain as comfortable and independent as possible.

Why Researchers Are Studying Cannabis for Dementia Symptoms

The body's endocannabinoid system helps regulate several functions that dementia commonly disrupts, including:

• Sleep
• Mood
• Anxiety
• Appetite
• Stress response

Cannabinoids interact with this system through receptors found throughout the brain and nervous system.

Researchers have studied:

• THC has been investigated in small studies examining symptoms such as appetite changes and behavioral disturbances.
• CBD has been studied in early research involving anxiety-related symptoms and behavioral changes. Unlike THC, CBD does not typically produce intoxicating effects.

Neither cannabinoid has been shown to slow, reverse, or cure dementia. Instead, researchers are examining whether they may help manage some of the symptoms that make daily life more difficult for patients and caregivers.

Evidence at a Glance

What Research Says About Agitation

Agitation is one of the most extensively studied dementia symptoms in cannabis research.

A 2024 randomized clinical trial led by Johns Hopkins University and Tufts University enrolled 75 patients with severe Alzheimer's-related agitation across five clinical sites.

Participants received either:

• Dronabinol (an FDA-approved synthetic form of THC)
• Placebo

After three weeks, patients receiving dronabinol experienced approximately a 30% reduction in agitation scores compared with placebo. Researchers reported improvements in agitation scores. The study also evaluated safety outcomes, but additional research is needed before drawing conclusions about how cannabinoids compare with other treatment approaches.

However, these findings apply specifically to pharmaceutical-grade dronabinol. The researchers emphasized that the results should not be generalized to medical cannabis products available through dispensaries, which vary considerably in cannabinoid composition, dosage, and formulation.

Although encouraging, this represents one relatively small study, and larger clinical trials are still needed.

What Does Research Say About CBD and Dementia?

CBD has attracted attention because it does not produce the intoxicating effects associated with THC.

Early studies have investigated CBD for:

• Anxiety
• Behavioral symptoms
• Sleep quality
• Inflammation

Some observational studies suggest CBD may help reduce anxiety and improve overall comfort in certain patients. However, the available evidence remains limited, and researchers have not yet established consistent clinical benefits across larger populations.

At present, CBD should be viewed as an area of ongoing research rather than an established treatment for dementia symptoms.

THC and Dementia: What Researchers Are Studying

THC has been studied more extensively than CBD for dementia-related moments when someone becomes anxious, restless, or difficult to comfort.

Research has primarily examined whether THC may help support:

• Reduced agitation
• Improved appetite
• Better sleep
• Lower nighttime restlessness

Because THC can also cause dizziness, sedation, or temporary confusion, older adults may be more sensitive to its effects than younger individuals.

Any consideration of THC should occur under the guidance of a licensed physician who can evaluate the patient's overall health, medications, and individual risk factors.

Can Cannabis Help With Sleep Problems?

Sleep disruption is extremely common in dementia.

Patients may:

• Wake frequently overnight
• Wander during the night
• Sleep during the day
• Experience "sundowning," where confusion and agitation worsen in the evening

A 2025 systematic review published in the Journal of Psychopharmacology analyzed ten studies involving 278 dementia patients.

Across the included studies, cannabinoids were associated with:

• Reduced agitation
• Improved sleep
• Better functional ability
• Higher caregiver satisfaction

Although these findings are encouraging, researchers noted that the studies varied considerably in quality, cannabinoid formulations, and patient populations. More large-scale clinical trials are needed before firm conclusions can be drawn.

Can Cannabis Help Improve Appetite?

Many people living with dementia gradually lose interest in eating.

Poor appetite can contribute to:

• Weight loss
• Frailty
• Reduced energy
• Poor overall health

Some research suggests THC may stimulate appetite in patients experiencing reduced food intake. However, most available evidence comes from smaller clinical studies and observational research rather than large randomized trials.

Whether cannabinoids are appropriate depends on the patient's overall medical condition, nutritional status, and current medications.

Does Cannabis Cause Dementia?

This is one of the most common questions researchers receive.

Current evidence does not show that cannabis causes dementia.

Some studies have linked heavy, long-term cannabis use-particularly when use begins during adolescence, to changes in memory, attention, and learning. These findings are distinct from Alzheimer's disease or other forms of dementia.

Researchers continue studying whether long-term cannabis exposure influences dementia risk later in life. At present, available evidence does not establish a causal relationship between cannabis use and dementia.

People already living with dementia represent a very different population than healthy younger adults, so these findings should not be interpreted interchangeably.

Potential Risks and Side Effects

Although current research suggests cannabinoids may help some behavioral symptoms associated with dementia, they are not appropriate for every patient.

Older adults are generally more sensitive to THC than younger adults and may experience side effects such as:

• Increased confusion
• Dizziness
• Excessive drowsiness
• Impaired balance and falls
• Temporary worsening of memory
• Low blood pressure when standing
• Interactions with existing medications

Many people living with dementia also take medications for blood pressure, sleep disorders, anxiety, depression, or behavioral symptoms. Because cannabinoids can interact with some prescription medications, any decision to use medical cannabis should begin with a physician who understands the patient's medical history and current treatment plan.

The goal is to carefully weigh potential benefits against possible risks for each individual.

Where the Evidence Falls Short

Cannabis research in dementia has grown significantly over the past few years, but important limitations remain. We still don't have all the answers.

The strongest clinical evidence comes from the 2024 Johns Hopkins and Tufts University trial involving 75 patients treated for three weeks with dronabinol. While the findings were encouraging, larger studies with longer follow-up periods are still needed.

A broader review of available evidence has also found mixed results. Some clinical trials reported improvements in agitation, sleep, or caregiver satisfaction, while others found little or no meaningful difference compared with placebo.

Researchers are also investigating whether cannabinoids interact with amyloid-beta plaques and other biological processes associated with Alzheimer's disease. So far, these findings come primarily from laboratory and animal studies rather than human clinical trials.

For that reason, these early discoveries should not guide treatment decisions until they are confirmed in well-designed studies involving people with dementia.

What Cannabis Cannot Do

It's equally important to understand what current research does not support.

Medical cannabis has not been shown to:

• Cure dementia
• Reverse Alzheimer's disease
• Restore lost memory
• Slow cognitive decline
• Prevent disease progression

Current evidence focuses on whether cannabinoids may help manage symptoms such as agitation, anxiety, disrupted sleep, and reduced appetite. Understanding the limits of the evidence is just as important as understanding its possibilities.

Keeping expectations realistic helps patients and caregivers make informed decisions alongside their healthcare team.

Are Edibles the Best Option for Dementia Patients?

Many caregivers search for the "best edibles for dementia patients," but there is no single product or formulation that works for everyone.

Edibles have several characteristics that deserve careful consideration:

• They take longer to begin working than inhaled products.
• Their effects can last significantly longer.
• Finding the right dose may be more difficult, especially in older adults who are sensitive to THC.

Depending on a patient's symptoms, medical history, and physician's recommendations, other routes of administration may be more appropriate.

Rather than choosing products based on online recommendations, caregivers should discuss cannabinoid formulation, dosage, and administration with a licensed physician familiar with medical cannabis.

How Dementia Patients May Qualify for Medical Cannabis

Medical cannabis eligibility varies by state.

Some states specifically list Alzheimer's disease or dementia as qualifying medical conditions. In states where dementia is not specifically listed, eligibility may depend on whether the patient's symptoms or diagnosis meet that state's qualifying condition requirements. Others evaluate patients based on symptoms associated with dementia, such as severe anxiety, agitation, chronic pain, or sleep disturbances.

A physician evaluation considers factors according to the requirements of the patient's state's medical cannabis program:

• The patient's diagnosis
• Current symptoms
• Existing medications
• Overall medical history
• State-specific eligibility requirements

Because regulations differ across medical cannabis programs, eligibility should always be assessed according to the laws of the patient's state.

When Should Caregivers Consider Talking to a Physician?

Many caregivers begin exploring medical cannabis after conventional treatment options no longer provide enough symptom relief or produce side effects that affect quality of life.

A conversation with a licensed physician may be appropriate if a person with dementia experiences:

• Persistent agitation
• Frequent nighttime wakefulness
• Anxiety affecting daily comfort
• Poor appetite leading to weight loss
• Behavioral symptoms that remain difficult to manage despite current treatment

A physician can review the patient's medications, discuss potential risks and benefits, and determine whether medical cannabis may be an appropriate option within the state's medical program.

How Doctors of Cannabis Can Help

If you're caring for someone experiencing severe agitation, disrupted sleep, anxiety, or appetite loss related to dementia, inding out whether they qualify under their state's medical cannabis program through a licensed physician may be a reasonable next step.

Our team helps patients understand the medical cannabis process, connects them with licensed physicians through a telehealth partner network, and provides guidance throughout the application journey.

Doctors of Cannabis connects patients to licensed physicians through our telehealth partner network. You only pay if approved.

Frequently Asked Questions

Key Takeaways

• Current evidence suggests cannabinoids may help manage agitation, sleep disturbances, anxiety, and appetite loss in some people living with dementia.
• The strongest evidence currently involves pharmaceutical-grade dronabinol for Alzheimer's-related agitation.
• Cannabis has not been shown to cure dementia, reverse Alzheimer's disease, or slow disease progression.
• Older adults may be more sensitive to THC, making physician supervision especially important.
• Decisions about whether to pursue medical cannabis access should be discussed with a licensed physician who can evaluate eligibility and individual circumstances.

Sources

• Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer's Disease - Johns Hopkins Medicine, 2024
• Updates on Cannabis Research for Alzheimer's Disease Symptoms - Cannabis Science and Technology, 2025
• Medical Cannabis for the Treatment of Dementia - NCBI Bookshelf

This article is authored by Dr. Erick Kaufman MD. Explore his other expert resources on medical cannabis.